EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Cause-Specific Mortality among Infants in a Randomized Controlled Trial of Azithromycin Compared to Placebo for Prevention of Mortality

Mamadou Ouattara, Ali Sié, Mamadou Bountogo, Valentin Boudo, Thierry Ouedraogo, Clarisse Dah, Elodie Lebas, Huiyu Hu, Aimee Lansdale, Ian Fetterman, Benjamin F Arnold, Thomas M Lietman und 1 weitere

The American Journal of Tropical Medicine and Hygiene · 2024

DOI: 10.4269/ajtmh.24-0186 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Mamadou Ouattara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso. Hauptthemen laut MEDLINE: Azithromycin, Infant Mortality, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although community randomized trials have found a reduction in all-cause child mortality in communities receiving mass azithromycin distribution compared with placebo, individually randomized trials have not found similar protective effects. If a direct effect of azithromycin for prevention of child mortality exists, it is likely due to reduction in infectious mortality. Here, we assessed cause-specific mortality in a large randomized controlled trial of azithromycin administered during well-infant visits in Burkina Faso for prevention of mortality. Among 32,877 enrolled infants, the most common causes of death by 6 months of age were malaria, acute respiratory infections, and diarrheal disease. We found no evidence of a difference in the distribution of cause of death by randomized treatment assignment ( P = 0.42) or in any infectious-specific cause of death. The results of this analysis are consistent with no direct effect of azithromycin on infant mortality when administered during well-infant visits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinInfant MortalityAnti-Bacterial AgentsHumansInfantBurkina FasoCause of DeathFemaleMaleRespiratory Tract InfectionsInfant, NewbornMalaria

Substanzen

AzithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
  • Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
  • Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California.
  • Department of Ophthalmology, University of California, San Francisco, San Francisco, California.

Zitieren

APA

Ouattara, M., Sié, A., Bountogo, M., Boudo, V., Ouedraogo, T., Dah, C., Lebas, E., Hu, H., Lansdale, A., Fetterman, I., Arnold, B. F., Lietman, T. M., & Oldenburg, C. E. (2024). Cause-Specific Mortality among Infants in a Randomized Controlled Trial of Azithromycin Compared to Placebo for Prevention of Mortality. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0186

Vancouver

Ouattara M, Sié A, Bountogo M, Boudo V, Ouedraogo T, Dah C, et al. Cause-Specific Mortality among Infants in a Randomized Controlled Trial of Azithromycin Compared to Placebo for Prevention of Mortality. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.24-0186

BibTeX
@article{Ouattara2024,
  author = {Ouattara, Mamadou and Sié, Ali and Bountogo, Mamadou and Boudo, Valentin and Ouedraogo, Thierry and Dah, Clarisse and Lebas, Elodie and Hu, Huiyu and Lansdale, Aimee and Fetterman, Ian and Arnold, Benjamin F and Lietman, Thomas M and Oldenburg, Catherine E},
  title = {Cause-Specific Mortality among Infants in a Randomized Controlled Trial of Azithromycin Compared to Placebo for Prevention of Mortality},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.4269/ajtmh.24-0186}
}
Kostenlos starten →